American Heart Association says Genetically-Modified Probiotic may one day treat Pulmonary Hypertension
September 20, 2016
American Heart Association Meeting Report Abstract 9
Orlando, FL – An oral, genetically-modified strain of the probiotic Lactobacillus was used to treat rats with high blood pressure in the lungs, which resulted in reduced blood pressure, improved heart contractility, and reduced heart wall thickness, according to a study presented at the American Heart Association’s Council on Hypertension 2016 Scientific Sessions.
High blood pressure in the lungs is known as pulmonary hypertension. In pulmonary hypertension, the heart must work harder to pump blood from the heart through the arteries of the lungs, which puts added strain on the heart.
An oral, genetically-modified strain of the probiotic Lactobacillus was used to treat rats with high blood pressure in the lungs, which resulted in reduced blood pressure, improved heart contractility, and reduced heart wall thickness. (American Heart Association)
